FTSE falls amid drug stock fears
Bad news for drugs stocks on both sides of the Atlantic injected negative sentiment into the London market today.
AstraZeneca lost nearly £3bn (€4.3bn) of its value after announcing a key product in its pipeline had failed to boost survival chances for some patients.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





